Klaus Ruhnau - Paul Hartmann Executive

Executive

Dr. Klaus Ruhnau is Managing Director of BODE Chemie GmbH of PAUL HARTMANN AG since 2014. Previously he was Head of Wound Management Business Division Corporationrationrate Marketing Services and Corporationrationrate Branding at the company. since 2014.
Tenure 10 years
Professional MarksPh.D
Phone49 7321 360
Webhttp://hartmann.info

Paul Hartmann Management Efficiency

The company has return on total asset (ROA) of 8.22 % which means that it generated a profit of $8.22 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 11.85 %, meaning that it generated $11.85 on every $100 dollars invested by stockholders. Paul Hartmann's management efficiency ratios could be used to measure how well Paul Hartmann manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 85.05 M in total debt with debt to equity ratio (D/E) of 0.09, which may suggest the company is not taking enough advantage from borrowing. Paul Hartmann AG has a current ratio of 2.13, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Paul Hartmann until it has trouble settling it off, either with new capital or with free cash flow. So, Paul Hartmann's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Paul Hartmann AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Paul to invest in growth at high rates of return. When we think about Paul Hartmann's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Joe PalmieriAptiv PLC
N/A
David MichaelShagrir Group Vehicle
54
Silas GreenUsio Inc
N/A
Bruce SchumanVacasa Inc
52
Harish NaiduVacasa Inc
N/A
Rebecca BoydenVacasa Inc
N/A
John MarcoUsio Inc
N/A
Paul ManleyUsio Inc
N/A
Robert MilneVacasa Inc
N/A
Pat WadorsServiceNow
52
Anelise SacksAnalog Devices
45
Obed LouissaintAptiv PLC
44
Sharon LennonMarine Products
N/A
Manu SivanandamVacasa Inc
N/A
Josie ArcherAptiv PLC
N/A
CFI CFEUsio Inc
N/A
Patrick ODohertyAnalog Devices
N/A
Matthew PetersonAptiv PLC
59
James MollicaAnalog Devices
57
Lisa ScalzoAptiv PLC
N/A
Matthew ColeAptiv PLC
54
Paul Hartmann AG manufactures and sells medical and care products in Europe, Africa, Asia, and Oceania. The company was founded in 1818 and is based in Heidenheim, Germany. Paul Hartmann operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 10625 people. Paul Hartmann AG [PLHNF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Paul Hartmann AG Leadership Team

Elected by the shareholders, the Paul Hartmann's board of directors comprises two types of representatives: Paul Hartmann inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Paul. The board's role is to monitor Paul Hartmann's management team and ensure that shareholders' interests are well served. Paul Hartmann's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Paul Hartmann's outside directors are responsible for providing unbiased perspectives on the board's policies.
Klaus Ruhnau, Head of Wound Management Business Division, Corporate Marketing Services and Corporate Branding
Werner Casper, Head of Customer Solution Management and Member of Supervisory Board
Andreas Joehle, Chairman of The Management Board and CEO
Gerhard Hirth, Member of the Supervisory Board
FritzJuergen Heckmann, Chairman of the Supervisory Board
Ralf Willeck, Member of the Supervisory Board, Employee Representative
Helmut Althammer, Member of the Supervisory Board
Joachim Schielke, Member of the Supervisory Board
Wolfgang Neumann, Chief Medical Officer and Member of the Management Board
Peter Donath, Member of the Supervisory Board, Employee Representative
Lubomir Palenik, Regional Director East Europe, Managing Director of HARTMANN-RICO a.s., Czech Republic
Monika Faber, IR Contact Officer
Horst Mund, Member of the Supervisory Board, Employee Representative
Michel Kuehn, COO and Member of the Management Board
Eduard Schleicher, Member of the Supervisory Board
Rinaldo Riguzzi, Member of the Supervisory Board
Joachim Bader, Member of the Supervisory Board, Employee Representative
Andreas Gisler, Managing Director of IVF HARTMANN GROUP, Switzerland
Raymund Heinen, Member of the Management Board, Chief Process Officer
Stephan Schulz, CFO, Labor Director and Member of Management Board
Christine Geppert, Member of the Supervisory Board, Employee Representative
Yvonne Brix, Member of the Supervisory Board, Employee Representative

Paul Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Paul Hartmann a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Paul Hartmann in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Paul Hartmann's short interest history, or implied volatility extrapolated from Paul Hartmann options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Paul Hartmann AG using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in Paul Pink Sheet

If you are still planning to invest in Paul Hartmann AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paul Hartmann's history and understand the potential risks before investing.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
CEOs Directory
Screen CEOs from public companies around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance